Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Small Cell Lung Carcinoma × Doxorubicin × Clear all

Phase

Phase 1 4 Phase 3 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 130 Lymphoma 91 Lymphoma, Large B-Cell, Diffuse 70 Sarcoma 56 Hodgkin Disease 41 Precursor Cell Lymphoblastic Leukemia-Lymphoma 34 Burkitt Lymphoma 31 Triple Negative Breast Neoplasms 27 Lymphoma, Mantle-Cell 26 Lymphoma, Non-Hodgkin 25 Lymphoma, Follicular 22 Leukemia 22 Neoplasms 19 Neoplasm Metastasis 18 Neuroblastoma 16 Multiple Myeloma 16 Ovarian Neoplasms 15 Carcinoma, Hepatocellular 15 Lymphoma, B-Cell 14 Prostatic Neoplasms 11 Osteosarcoma 11 Liver Neoplasms 11 Urinary Bladder Neoplasms 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10 Lymphoma, T-Cell, Peripheral 10 Lymphoma, Large-Cell, Anaplastic 10 Breast Neoplasms, Male 10 Lymphoma, Large-Cell, Immunoblastic 9 Dendritic Cell Sarcoma, Interdigitating 9 Inflammatory Breast Neoplasms 8

Interventions

Etoposide 70 Carboplatin 60 Cisplatin 40 Topotecan 26 durvalumab 25 atezolizumab 18 Radiotherapy 18 Irinotecan 18 Paclitaxel 15 Nivolumab 15 apatinib 14 anlotinib 12 Drug Therapy 12 pembrolizumab 9 Platinum 9 toripalimab 8 Bevacizumab 8 Radiosurgery 7 PM 01183 7 Ipilimumab 7 tislelizumab 6 Gemcitabine 6 olaparib 5 amrubicin 5 Temozolomide 5 Sunitinib 5 Pemetrexed 5 Docetaxel 5 Albumin-Bound Paclitaxel 5 irinotecan sucrosofate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00483509 2019-10-04

NGR007

AGC Biologics S.p.A.

Phase 2 Completed

28 enrolled 10 charts

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡